Campbellteaching
Hello Everyone, My name is John Campbell and I am a retired Nurse Teacher and former clinical nurse based in England. I also do some teaching in Asia and Africa when time permits. These videos are to help students to learn the background to all forms of health care. My PhD focused on the development of open learning resources for nurses nationally and internationally. LinkedIn profile, https://www.linkedin.com/in/dr-john-campbell-5256223b/ Twitter, https://twitter.com/Johnincarlisle Disclaimer; These media including videos, book, e book, articles, podcasts are not peer-reviewed. They should never replace individual clinical judgement from your own health care provider. No media-based material on this channel is suitable for using as professional medical advice. All comments are also for educational purposed only and must never replace advice from your own health care provider
Isle of Wight mushroom farm, https://www.iwmushrooms.co.uk/ I have no commercial intrest in this but it is where I get my Lion's mane tuncture from and I visited the farm myself, on this video https://www.youtube.com/watch?v=1UTX8SFDlUM Uploaded 22-07-25 Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Read the link to the original paper, https://www.mdpi.com/2072-6643/13/10/3596 Uploaded 17-11-21 Deficiency of vit D limits the performance of systems resulting in, increased spread of diseases of civilization Reduced protection against infections Reduced effectiveness of vaccination Covid fatality rates correlate with, Elderly, dark, black people, comorbidities, winter Blood level of 20 ng/mL, (50 nmol/L) sufficient to stop osteomalacia Preferable, 40–60 ng/mL (100 to 150 nmol/L) Vitamin D3 receptors Bone Intestine Pancreas Prostate Immune system cells Vitamin D is a powerful epigenetic regulator Influencing more than 2,500 genes Cancer Diabetes mellitus Acute respiratory tract infections Viral lung infections that cause ARDS Chronic inflammatory diseases Autoimmune diseases Multiple sclerosis Immunomodulatory properties Regulating innate and adaptive immune systems D3 receptors Monocytes/macrophages T cells B cells Natural killer (NK) cells Dendritic cells (DCs) Supplements Without calcium supplementation, even very high vitamin D3 supplementation does not cause vascular calcification Vitamin D3 supplementation in the range of 4000 to 10,000 units (100 to 250 µg) needed to generate an optimal 40–60 ng/mL (100 to 150 nmol/L) has been shown to be completely safe when combined with approximately 200 µg vitamin K2 https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-k/ However, this knowledge is still not widespread in the medical community, and obsolete warnings about the risks of vitamin D3 overdoses unfortunately are still commonly circulating. ARDS and cytokine release syndrome Vitamin D3 is able to inhibit the underlying metabolic pathways Vitamin D3 has a protective role against ARDS caused by SARS-CoV-2. A rapidly increasing number of publications are investigating the vitamin D3 status of SARS-CoV-2 patients, and have confirmed low vitamin D levels in cases of severe courses of infection and positive results of vitamin D3 treatments Conclusions we recommend raising serum 25(OH)D levels to above 50 ng/mL (100 to 150 nmol/L) to prevent or mitigate new outbreaks due to escape mutations or decreasing antibody activity. At a time when vaccination was not yet available, patients with sufficiently high D3 serum levels preceding the infection were highly unlikely to suffer a fatal outcome. This correlation should have been good news when vaccination was not available but instead was widely ignored. the lower threshold for healthy vitamin D levels should lie at approximately 125 nmol/L or 50 ng/mL 25(OH)D3, which would save most lives, reducing the impact even for patients with various comorbidities. This is—to our knowledge—the first study that aimed to determine an optimum D3 level to minimize COVID-19 mortality Implications for herd immunity It seems clear that a good immune defense, does not prove protection against physical infection but rather against its consequences This “protection” was most effective at ~55 ng/mL Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/traditionally-living-populations-in-east-africa-have-a-mean-serum-25hydroxyvitamin-d-concentration-of-115-nmoll/6188564A01361C5CF5F196229430E475 natural vitamin D3 levels seen among traditional hunter/gatherer lifestyles, in a highly infectious environment, were 110–125 nmol/L (45–50 ng/mL) WHO advice may not be correct 30 ng/mL D3 value considered by the WHO as the threshold for sufficiency Future mutations of the SARS-CoV-2 virus, vaccine immune escape the entire population should raise their serum vitamin D level to a safe level as soon as possible. As long as enough vitamin K2 is provided, the suggested D3 levels are entirely safe to achi Learn more about your ad choices. Visit megaphone.fm/adchoices
Is there a crisis of trust? Uploaded 13-10-21 https://ourworldindata.org/coronavirus John's free textbooks Download my two comprehensive but free educational text books or make a donation to the campbellteaching project using this link: http://159.69.48.3Russia https://www.youtube.com/watch?v=ijgNJpUes4Y https://www.dailymail.co.uk/news/article-10084049/Video-showing-Putin-coughing-meeting-emerges-forced-deny-having-Covid-19.html Infections, + 29,409 Deaths, + 973 = 217,000 Delta variant Vaccine hesitancy First dose, 33% Rolled out before trials Problem is not that bad Government had won the war on covid-19 Mr. Putin pulls out of G20 meeting due to 'diary clash' Two doses of Sputnik V ITU, 8,000 patients Patients becoming critical in 3 to 4 days Vaccination passports cost 70 euros Widespread public misconceptions Hygiene rules hardly followed Limited restrictions Limited mask wearing Official information not believed Indian summer just now Moscow may well cope New infectious disease hospital Regions, hospitals already full Molnupiravir, Merck, awaiting EMU US government at $700 (£515) per course Analysts at Harvard School of Public Health and King's College Hospital in London have found it costs just $17.74 (£13) to produce. Despite this, Merck and Ridgeback could earn $7 billion in profits by the end of the year. https://news.sky.com/story/covid-news-uk-latest-live-experts-discover-why-people-get-covid-toes-as-wales-introduces-vaccine-passports-12425651 https://www.fiercepharma.com/pharma/merck-molnupiravir-blockbuster-covid-19-pandemic-endemic-oral-antivirals-market That’s about $700 per course. Merck said it expects to make 10 million courses of the drug by the end of 2021, meaning $7 billion in revenue BBC Media Action £1,569,000 in 2019 - 2020 https://www.bbc.co.uk/mediaaction/about/funding https://www.bbc.co.uk/mediaaction/about/annual-reports https://www.bbc.co.uk/mediaaction/where-we-work We support the independent media essential to democracy and development. We inform, connect and inspire change in our audiences, providing trusted information, stories and ideas that generate discussion and bridge divides. helping to save lives and improve health, protect livelihoods, challenge inequality and build more peaceful and democratic societies. Coronavirus: lessons learned to date https://committees.parliament.uk/publications/7496/documents/78687/default/ in 2020 the UK did significantly worse in terms of covid deaths than many countries—especially compared to those in East Asia The UK’s pandemic planning was too narrowly and inflexibly based on a flu model which failed to learn the lessons from SARS, MERS and Ebola. In the first three months the strategy reflected official scientific advice to the Government which was accepted and implemented. When the Government moved from the ‘contain’ stage to the ‘delay’ stage, that approach involved trying to manage the spread of covid through the population rather than to stop it spreading altogether. This amounted in practice to accepting that herd immunity by infection was the inevitable outcome, The UK, along with many other countries in Europe and North America made a serious early error in adopting this fatalistic approach and not considering a more emphatic and rigorous approach to stopping the spread of the virus as adopted by many East and South East Asian countries. The fact that the UK approach reflected a consensus between official scientific advisers and the Government indicates a degree of groupthink that was present at the time which meant we were not as open to approaches being taken elsewhere as we should have been. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
COVID-19 vaccine mandates should not discriminate against natural immunity, The unnaturalistic fallacy Uploaded 21-06-22 https://jme.bmj.com/content/48/6/371 COVID-19 vaccine requirements, debate, policies should have recognised proof of natural immunity, sufficient basis for exemption to vaccination requirements. Arguments Two implausible claims about natural immunity: Natural immunity is superior to ‘artificial’ immunity It is better to acquire immunity through natural infection Naturalistic fallacy (many things are natural, but not good) (A natural public health strategy, increased overall morbidity and mortality) We lack clear and convincing scientific evidence that vaccine-induced immunity has a significantly higher protective effect than natural immunity. Vaccine requirements represent a substantial infringement of individual liberty, and other significant costs Can only be justified if they are necessary for achieving a proportionate public health benefit. Without compelling evidence for the superiority of vaccine-induced immunity, it cannot be deemed necessary to require vaccination for those with natural immunity. ‘vaccine passports’ ‘health passes’ Rationale for vaccine mandates Preventing healthcare systems becoming overwhelmed, (staff and patients) Reducing community viral transmission Acquired immunity naturally, potentially equivalent to vaccination immunity This is the unnaturalistic fallacy as opposed to the naturalistic fallacy Natural immunity and vaccine-induced immunity, evidence Equivalency of Protection From Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis https://www.cureus.com/articles/72074-e All of the included studies found at least statistical equivalence between the protection of full vaccination and natural immunity; and, three studies found superiority of natural immunity. NNT to prevent one annual case of infection in COVID-recovered patients 218 NNT COVID-naïve patients, 6.5 33.5-fold difference in benefit between the two populations our review demonstrates that natural immunity in COVID-recovered individuals is, at least, equivalent to the protection afforded by complete vaccination of COVID-naïve populations Vaccinations for recovered people, marginal on an absolute basis. Omicron in adults aged 65 or over minimal or no effect against mild disease with the Omicron variant from 20 weeks after the second dose of ChAdOx1-S or BNT162b2 data are beginning to emerge which suggest that the effect of the vaccines on transmission may diminish within a matter of months Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection https://www.science.org/doi/abs/10.1126/science.abf4063 Immunological memory is the basis for durable protective immunity after infections or vaccinations. Substantial immune memory is generated after COVID-19, involving, memory B cells, antibodies, memory CD4+Tcells, memoryCD8+T cells. Circulating antibody titers were not predictive of T cell memory. Do not reflect the richness and durability of immune memory to SARS-CoV-2. Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study https://academic.oup.com/cid/article/73/10/1882/6170939?login=true N = 150,325 patients 8,845 (5.9%) 141,480 (94.1%) Protection against reinfection, 81.8% Protection against symptomatic reinfection, 84.5% Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden https://www.sciencedirect.com/science/article/pii/S1473309922001438 Cohort one, 2,039,106 Cohort two, 962,318 one dose Cohort three, 567,810 two doses 767 individuals with natural immunity needed to be vaccinated to prevent one rein Learn more about your ad choices. Visit megaphone.fm/adchoices
White House, Lab leak publication Uploaded 04-05-25 https://www.whitehouse.gov/lab-leak-true-origins-of-covid-19/ Top secret US research lab studying SARS-CoV-2 shut amid safety concerns, May 2025 https://www.telegraph.co.uk/global-health/science-and-disease/us-research-lab-studying-sars-cov-2-shut-amid-safety-fears/?WT.mc_id=e_DM575996&WT.tsrc=email&etype=Edi_GHS_New_Fri&utmsource=email&utm_medium=Edi_GHS_New_Fri20250502&utm_campaign=DM575996 The Integrated Research Facility (IRL) in Fort Detrick, Maryland Biosafety-level-4 (BSL4) High security lab at Fort Detrick, linked by Chinese propagandists to the outbreak of Covid-19 - without evidence US research facility that studies Sars-CoV-2, Ebola, Lassa fever, Marburg and Eastern equine encephalitis (high consequence diseases) Has been shut down by the Trump administration amid safety concerns. NIH has implemented a research pause – a safety stand-down Told by email to stop all experimental work by 5pm on April 29 Identification and documentation of personnel issues involving contract staff that compromised the facility’s safety culture China released a paper “Substantial evidence suggested the Covid-19 might have emerged in the United States earlier than its officially-claimed timeline, and earlier than the outbreak in China,” Prof Stuart Neil, head of infectious diseases at King’s College London. “The sustained attacks on collaborative US biomedical science and public health are already destroying disease surveillance systems and game-changing clinical trials that will result in avoidable deaths and morbidities for years to come in some of the poorest countries,” This is wilful vandalism of research and treatment programmes that have taken years to establish – things that you could legitimately say made America great,” Prof Francis Collins Led the NIH for 12 years “more children and adults in low-income countries will now lose their lives because of research that didn’t get done”. Full text: Covid-19 Prevention, Control and Origins Tracing: China's Actions and Stance http://english.scio.gov.cn/whitepapers/2025-04/30/content_117854036_4.html Evidence Pointing to the US as the Origin of Covid-19 Numerous studies have shown that SARS-CoV-2 originated outside China. prior to the outbreak in Wuhan, multiple regions in the US recorded positive SARS-CoV-2 test results and other evidence of the virus It (US) must promptly respond to the legitimate concerns of the international community, proactively share with the WHO data on its early suspected cases, disclose information about Fort Detrick, its global network of biological laboratories, and the so-called research conducted therein, and provide a responsible account to the global public. Between 2006 and 2013 US reported at least 1,500 serious laboratory incidents involving SARS, MERS, Ebola, anthrax, smallpox, and avian influenza. China prioritized lives and health above all else, and implemented comprehensive, science-based and effective containment measures. … and to expose the mismanaged pandemic response in the United States. China has always applied a science-based approach to the task of tracing the virus origins, actively engaging with the WHO Contributing Chinese Wisdom to the Study of the Origins of SARS-CoV-2 To date, no findings have contradicted the conclusions of the "Joint WHO-China Study". It is fair to say that the study on the origins of SARS-CoV-2 conducted in China has ended. 2. China's Open and Transparent Updates on Its Findings Regarding the Origins of the Virus China conducted systematic testing on more than 80,000 samples collected from bats, pangolins, wild birds, wild boars, raccoon dogs, and other wildlife, as well as livestock and poultry across the country. 2017 to 2021 samples analyses detected no evidence of SARS-CoV-2 circulation in these animal populations. Learn more about your ad choices. Visit megaphone.fm/adchoices
With Professor Robert Clancy. Uploaded 06-03-25 Link to Quadrant, https://quadrant.org.au/news-opinions/uncategorized/after-covid-now-its-the-lawyers-turn/ Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up https://www.medrxiv.org/content/10.1101/2024.11.13.24317190v1 Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults https://academic.oup.com/cid/article/78/5/1372/7450138 Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States https://www.nature.com/articles/s41467-024-45549-9 Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada https://academic.oup.com/cid/article/75/11/1980/6570607 COVID-19 mRNA VACCINES: THE PROBLEM THAT WON’T GO AWAY. Emeritus Professor Robert Clancy AM This month we ‘celebrate’ 5 years since the covid pandemic began in Australia. This is the 10th article I have written for Quadrant on covid pandemic management. Prior to the pandemic my 300+ publications had been in peer reviewed medical journals. Most reported research on airway immune protection which has been my passion for 50 years. In 2019 the University of Newcastle awarded me a Doctor of Science for this work (I was informed that this was the first such award given by the University). My point is that in 2020 with the appearance of SARS-CoV-2 (the virus causing Covid-19), entirely by circumstance, I was as well placed as anyone to understand this new airway infection, its pathogenesis and its management. Specifically, the likely place for vaccination in the control of the pandemic. That is what I did. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Cause of the autism pandemic. Uploaded 18-04-25 Endogenous, Exogenous Sociological / psychological Food Environmental toxin Iatrogenic, drugs, vaccinations Cocktail effect ‘Autism Epidemic Runs Rampant,’ New Data Shows 1 in 31 Children Afflicted https://www.hhs.gov/press-room/autism-epidemic-runs-rampant-new-data-shows-grants.html WASHINGTON, DC—APRIL 15, 2025 Autism prevalence in the U.S (at 8 years of age) 2021, one in 36 children 2022, one in 31 children 1 in 31 is 3.22% https://www.cdc.gov/mmwr/volumes/74/ss/ss7402a1.htm?s_cid=ss7402a1_w U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy “The autism epidemic is running rampant,” “One in 31 American children born in 2014 are disabled by autism. That’s up significantly from two years earlier and nearly five times higher than when the CDC first started running autism surveys in children born in 1992 https://www.cdc.gov/mmwr/preview/mmwrhtml/ss5601a1.htm Prevalence for boys is an astounding 1 in 20 and in California it’s 1 in 12.5.” “President Trump has tasked me with identifying the root causes of the childhood chronic disease epidemic -- including autism,” “We are assembling teams of world-class scientists to focus research on the origins of the epidemic, and we expect to begin to have answers by September.” The new (ADDM) Autism and Developmental Disabilities Monitoring report Conducted in 2022 across 16 sites in the U.S. Surveyed children aged 8 years born in 2014. Autism prevalence in 2000 One in 150 children Now, (well, 2022 data), one in 31 4.8 times higher 2022 compared to 2020 4.8 times higher Increasing intellectual disability among those effected Percentage of ASD cases with lower IQs has increased Nearly two thirds of children with ASD in 2022 data had either severe or borderline intellectual disability (ID). IQ less than 70 Arizona 31 % Arkansas 43.3 % California 28.4 % Prevalence of ASD by sex in 2022 (8 years) Boys, 49.2 per 1,000 (4.92%) Girls, 14.3 per 1,000 (1.4%) Male-to-female prevalence ratio was 3.4 Prevalence by ethnicity in 2022 (8 years) Black children 3.66 % Asian children 3.82 % Hispanic children 3.3 % White children 2.77 % Severe or borderline ID (8 years) Black children 78.9 % Asian children 66.5 % Hispanic children 63.9 % White children 55.6 % This report exposes a series of critical public health crises A persistent rise in ASD prevalence An alarming escalation in case severity Increasingly stark disparities across racial and ethnic groups This also highlights the urgent need for real-time data. HHS Secretary Robert F. Kennedy “The autism epidemic has now reached a scale unprecedented in human history because it affects the young,” “The risks and costs of this crisis are a thousand times more threatening to our country than COVID-19. Autism is preventable and it is unforgivable that we have not yet identified the underlying causes. We should have had these answers 20 years ago.” UK also dramatic rise in autism https://digital.nhs.uk/supplementary-information/2024/autism-prevalence-in-england-march-2024 https://www.priorygroup.com/mental-health/autism/autism-statistics June 2024 Boys, prevalence rate 2.8%. Girls, prevalence rate 0.65% 193,203 to 204,000 referred for suspected autism, awaiting assessment or diagnosis 1998 and 2018 787% rise A 2023 study, people aged 20 to 49 150,000 to 500,000, in England may be autistic but undiagnosed. Antipsychotics are prescribed to about 2.1% of autistic children and young people, with usage increasing with age Rates of co-occurring bipolar disorder in autism In children, 7.8% In adults, 15% Title of Brownstone article withheld my me https://brownstone.org/articles/vaccines-autism-and-brownstone/ That’s how much taboo there is around this subject, which is itself deeply strange. If science is simply a Learn more about your ad choices. Visit megaphone.fm/adchoices
As cases and infections surge, hospital admissions do not UK, 24th December Omicron hospital patients, 366 Total omicron deaths, 29 UK, 27th December Omicron hospital patients, 407 Total omicron deaths, 39 Omicron cases + 45,307 = 159,932 UK data https://www.gov.uk/government/publications/covid-19-omicron-daily-overview https://covid.joinzoe.com/data#levels-over-time https://coronavirus.data.gov.uk In hospital patients, UK In hospital patients, London A testing site, Upper West Side of Manhattan Sunday 4pm local time They are getting a 50% hit rate Hit rate has doubled each of the past three days Michael Very mild symptom sets, not even as bad as a normal cold for me, and it seemed to be the same for everyone on line. I tested positive and I was surprised, given how mild the symptoms are. Slightly blocked feeling, feeling of being a little ill for one day, slight headache, no cough or runny nose. This surprised me because I havebeen practicing extreme isolation. I live alone (by choice), and only visited the supermarket during off hours, twice in the past 7-10 days. Amazing that I got this. I started with 4000 IU of D per day about three or four weeks ago. And 15 mcg daily of zinc. Who knows this may explain the mild symptom set. US cases and deaths data https://covid.cdc.gov/covid-data-tracker/#trends_dailycases Isolation down to 5 days is asymptomatic https://www.cdc.gov/media/releases/2021/s1227-isolation-quarantine-guidance.html Followed by 5 days mask wearing One to two days before day one, then 2 to 3 days after this Dr. Rochelle Walensky The Omicron variant is spreading quickly and has the potential to impact all facets of our society. CDC’s updated recommendations for isolation and quarantine balance what we know about the spread of the virus and the protection provided by vaccination and booster doses. These updates ensure people can safely continue their daily lives. Prevention is our best option: get vaccinated, get boosted, wear a mask in public indoor settings in areas of substantial and high community transmission, and take a test before you gather. US hospitalizations https://covid.cdc.gov/covid-data-tracker/#hospitalizations US, Health and Human Services https://protect-public.hhs.gov/pages/hospital-utilization SA data SA hospital data https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/ https://www.worldometers.info/coronavirus/country/south-africa/ Australia https://www.health.gov.au/health-alerts/covid-19/case-numbers-and-statistics https://www.youtube.com/watch?v=6ZeJVfcobhc REVISION TO CONTACT TRACING, QUARANTINE AND ISOLATION PROTOCOLS: 23.12.2021 https://sacoronavirus.co.za/2021/12/24/circular-revision-to-contact-tracing-quarantine-and-isolation-protocols-23-12-2021/ Proportion of people with some immunity from infection and/or vaccination is high, Past infection in 60-80% in several sero-surveys Containment strategies are no longer appropriate – mitigation is the only viable strategy New knowledge about the virus High proportion of asymptomatic disease High degree of asymptomatic and pre-symptomatic spread Aerosol spread Only a small proportion of cases are diagnosed Testing Testing skewed towards symptomatic (minority) Not all symptomatic people test Not all negative tests are true negatives Quarantine has been costly Thus, the following is applicable with immediate effect: All contact tracing be stopped with immediate effect, except in congregate settings and cluster outbreak situations or self-contained All contacts must continue with their normal duties with heightened monitoring (daily temperature testing, symptom screening) of any early signs. If they develop symptoms then they should be tested and be managed according to the Learn more about your ad choices. Visit megaphone.fm/adchoices
ONS vaccination data Uploaded 18-10-22 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/vaccines In the UK by the end of August 2022, of those aged 12 years and over: 93.6% had received a first dose of a COVID-19 vaccine 88.2% had received a second dose 70.2% had received three or more doses Therefore 6.4% of over 12s are totally unvaccinated Weekly national Influenza and COVID-19 surveillance report Week 41 report (up to week 40 data) 13 October 2022 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1110820/Weekly_Flu_and_COVID-19_report_w41.pdf (Page 74) Cumulative data up to week 40 2022 (week ending 9 October 2022) was extracted from the National Immunisation Management Service (NIMS). The vaccine uptake rate, aged 18 and over 82.5% for dose 1 79.7% for dose 2 65.8% for dose 3 UK, HSA Therefore 17.5% of over 18s are totally unvaccinated UK, ONS Therefore 6.4% of over 12s are totally unvaccinated Given that vaccination rates are lower in 12 to 18, as compared to over 18s, We would expect the percentage of unvaccinated in over 12s to be higher. So his discrepancy is even greater that it appears Vaccine rates are lower between 12 to 18 (compared to over 18s) Implications of the Office for National Statistics estimates of Covid-19 vaccine take up in England on the representativeness of its sample population (October 2022) https://www.researchgate.net/publication/364310694_Implications_of_the_Office_for_National_Statistics_estimates_of_Covid-19_vaccine_take_up_in_England_on_the_representativeness_of_its_sample_population?channel=doi&linkId=63459d419cb4fe44f31d90fd&showFulltext=true Most recent vaccine mortality surveillance report the UK's Office for National Statistics (ONS), estimated just 8% of adults in England were unvaccinated by the end of May 2022. However, the ONS estimates are based on a special subset of the England population. Other independent estimates for the whole of the population in May were higher: the UK Health Security Agency (UKHSA) estimated 20%, while a large independent survey by ICM found 26%. https://www.icmunlimited.com/our-work/exploring-attitudes-towards-covid-19-vaccinations-for-stv/ Assuming the ONS estimate is correct for its subset of the England population, and that the other independent estimates of between 20 and 26% for the whole population are also correct, then between 69% and 99.6% of adults missing from the ONS sample are unvaccinated. This would mean the ONS sample is unrepresentative of the whole England population and any conclusions about vaccine take-up, efficacy and safety based on the ONS data may not be relevant to the population as a whole. If the ONS is not underestimating the proportion of unvaccinated in its sample, then we have shown that the sample is so unrepresentative of the whole population that any inferences made about the vaccination programme using the ONS data are worthless. YT Guidelines COVID-19 medical misinformation policy https://support.google.com/youtube/answer/9891785 Prevention misinformation: Content that promotes prevention methods that contradict local health authorities or WHO. https://support.google.com/youtube/answer/11161123 Vaccine safety: content alleging that vaccines cause chronic side effects, outside of rare side effects that are recognized by health authorities Efficacy of vaccines: content claiming that vaccines do not reduce transmission or contraction of disease Ingredients in vaccines: content misrepresenting the substances contained in vaccines Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Professor Sherif Sultan, MB BCh MCh MD FRCSI DEVS FISVS FASA DMD FRCS/Vasc EBQS/Vasc FAARM FACS FEVBS PhD Professor of Vascular & Endovascular Surgery National University of Ireland Chief of Vascular & Endovascular Surgery at The Galway Clinic Chairman of Western Vascular Institute President of International Society for Vascular Surgery University Hospital Galway NUIG & The Galway Clinic https://acrobat.adobe.com/id/urn:aaid:sc:EU:ea3bf115-1a02-4440-a153-6ec0149f258a https://acrobat.adobe.com/id/urn:aaid:sc:EU:95fadfe1-88d4-4708-8729-ef38596cdcee https://acrobat.adobe.com/id/urn:aaid:sc:EU:a4572ad8-0375-4aa7-a6a7-b9ad0a8d78ca https://acrobat.adobe.com/id/urn:aaid:sc:EU:8a9f87d0-e9a3-4af5-9675-d9dfe4f91e28 https://acrobat.adobe.com/id/urn:aaid:sc:EU:779ab225-f4bf-4757-a540-62e7036c3fef https://acrobat.adobe.com/id/urn:aaid:sc:EU:893d701f-acd0-4f03-bba3-1a8e0ca8fc2e Learn more about your ad choices. Visit megaphone.fm/adchoices
Direct links to Marc’s book and substack Amazon.com (USA) https://www.amazon.com/NEEDLES-SECRET-UNRAVELING-MYSTERY-REVOLUTION/dp/B0CYLSCMHN/ref=cm_cr_arp_d_product_top?ie=UTF8 UK Amazon https://www.amazon.co.uk/NEEDLES-SECRET-UNRAVELING-MYSTERY-REVOLUTION/dp/B0CYLSCMHN/ref=cm_cr_arp_d_product_top?ie=UTF8 Australia Amazon https://www.amazon.com.au/NEEDLES-SECRET-UNRAVELING-MYSTERY-REVOLUTION/dp/B0CYLSCMHN/ref=cm_cr_arp_d_product_top?ie=UTF8 The Bolus Theory Series on Substack https://covidmythbuster.substack.com My Bolus Theory website https://marcgirardot.com Learn more about your ad choices. Visit megaphone.fm/adchoices
Is UK government data accurate? Or is there under-reporting? Uploaded 29-10-21 https://coronavirus.data.gov.uk https://covid.joinzoe.com/data#levels-over-time https://www.youtube.com/watch?v=Hc7A1bVuSJU https://covid.joinzoe.com/post/worryingly-close-to-100-000-new-cases-a-day Poor lateral flow test reporting Less than 50% have government ‘classical symptoms’ Therefore, government under testing Loss of smell and taste, 6 Fever, 8 ONS https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights Overall, coronavirus (COVID-19) infections continued to increase in England in the most recent week Percentage testing positive still highest in those in school years 7 to 11 Overall prevalence increases up to W/E 23rd October 2.02% in England (1 in 50 people) Week before, 1.79% (1 in 55 people) 2.56% in Wales (1 in 40 people) Week before, 2.31% (1 in 45 people) 1.31% in Northern Ireland (1 in 75 people) Week before, 0.76% (1 in 130 people) 1.36% in Scotland (1 in 75 people) Week before, 1.14% (1 in 90 people) Coronavirus antibodies remain high among UK adults (W/E 3rd October) https://blog.ons.gov.uk/2021/04/28/antibodies-and-immunity-how-do-they-relate-to-one-another/ 92.2% in England 90.0% in Wales 90.8% in Northern Ireland 91.3% in Scotland Positivity has increased in younger adults Showing signs of a slow decline in older adults Antibody finger prick tests A negative antibody test does not mean that a person is not protected Building up to 150,000 UK antibody tests per month Every month for the next year Coronavirus (COVID-19) deaths Between 13 March 2020 and 1 October 2021, 119,869 excess deaths above the five-year average Government figures https://coronavirus.data.gov.uk/details/deaths 140,392 163,515 Current UK deaths (ONS) 12,845 per week 14.8% above average Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Next up , BA.2.75, Centaurus Uploaded 14-07-22 https://www.who.int/activities/tracking-SARS-CoV-2-variants https://www.medpagetoday.com/special-reports/exclusives/99655 https://www.forbes.com/sites/williamhaseltine/2022/07/11/ba275-a-dark-horse-in-the-covid-pandemic/ India, early May, spreading fast (50%) (India has low levels of BA.5) Seems to be displacing previous omicrons Looks like an influenza type model will not work Detected in the Bay area, UK, Australia, Germany, Canada, Netherlands European Centre for Disease Prevention and Control (ECDC) https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea variant under monitoring 7th July Nine new spike protein mutations Amino acid changes, evade some neutralizing antibodies G446S, RBD (was Glycine now Serine) Individual response will be influenced by immune history BA.1 immunity, may be protective Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 Pandemic https://www.researchgate.net/publication/377266988_Excess_Deaths_in_the_United_Kingdom_Midazolam_and_Euthanasia_in_the_COVID-19_Pandemic Citation: Wilson Sy (2024) Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 Pandemic. Medical & Clinical Research, 9(2), 01-21. Macro-data during the COVID-19 pandemic in the United Kingdom (UK) are shown to have significant data anomalies and inconsistencies with existing explanations. England 2020 UK spike in deaths, wrongly attributed to COVID-19 in April 2020, was not due to SARS-CoV-2 virus, which was largely absent, but was due to the widespread use of Midazolam injections, which were statistically very highly correlated (coefficient over 90 percent) with excess deaths in all regions of England during 2020. Importantly Excess deaths remained elevated following mass vaccination in 2021, but were statistically uncorrelated to COVID injections, while remaining significantly correlated to Midazolam injections. The widespread and persistent use of Midazolam in UK suggests a possible policy of systemic euthanasia. Unlike Australia, where assessing the statistical impact of COVID injections on excess deaths is relatively straightforward, UK excess deaths were closely associated with the use of Midazolam and other medical intervention. The UK iatrogenic pandemic Caused by euthanasia deaths from Midazolam and also, likely caused by COVID injections, https://www.researchgate.net/publication/374261986_Early_Indication_of_Long-Term_Impact_of_COVID_Injections but their relative impacts are difficult to measure from the data, due to causal proximity of euthanasia. Global investigations of COVID-19 epidemiology, based only on the relative impacts of COVID disease and vaccination, may be inaccurate, due to the neglect of significant confounding factors in some countries. Learn more about your ad choices. Visit megaphone.fm/adchoices
Right now there is no obvious replacement for the BA.5 variant, that is causing the current wave. This leaves open the real possibility that this could be the last significant wave this year, (or hopefully much longer). Uploaded 06-08-22 https://covid.cdc.gov/covid-data-tracker/#variant-proportions BA.5 85.5% BA.4 7.7% BA.4.6 4.1 BA2.12.1 2.6% BA.2 0.1% BA.1s 0% BA. 2.75 not US listed US hospitalizations Down 3.8% on the week Known daily case counts, test positivity, hospitalizations slow downward trend US deaths https://covid.cdc.gov/covid-data-tracker/#trends_dailydeaths_select_00 Last 7 days rolling average, 393 per day Dr. Fauci (81), Re. BA.5 https://www.washingtonpost.com/health/2022/08/05/fauci-vaccine-covid-trouble/?utm_campaign=wp_to_your_health&utm_medium=email&utm_source=newsletter&wpisrc=nl_tyh If they don’t get vaccinated or they don’t get boosted, they’re going to get into trouble Wants to increase vaccination and booster rates, so the virus does not have, ample opportunity to freely circulate It is about you as an individual, but it’s also about the communal responsibility to get this outbreak under control (POTUS, fully vaccinated and double boosted) Weekly national Influenza and COVID-19 surveillance report https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1096288/Weekly_Flu_and_COVID-19_report_w31.pdf COVID-19 activity decreased Highest number of respiratory incidents, (mostly SARS-CoV-2) in care homes Influenza positivity, 0.5% RSV positivity up to 6.5% overall RSV positivity in under 5s, 22.2% Rhinovirus positivity, down to 8.4% Symptom tracker data https://health-study.joinzoe.com/data New cases per day, 145,740 Current prevalence, 2,858,159 UK official data https://coronavirus.data.gov.uk ONS latest https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights 3.86% in England (1 in 25 people) 3.58% in Wales (1 in 30 people) 5.98% in Northern Ireland (1 in 17) 4.95% in Scotland (1 in 20) Long covid, as of 2 July 2022 1.8 million people, (2.8% of the population) Of those, 81% experiencing long COVID symptoms at least 12 weeks 43% at least one year Antibodies 179ng/ml level and the 800ng/ml theshold Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Most people in England have been naturally infected. Link to free download of my 2 textbooks Uploaded 23-04-22 http://159.69.48.3/ https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights 22 April 2022 27th April 2020 to 11th February 2022 70.7% in England are estimated to have had COVID-19 The estimated percentage of the community population (those not in hospitals, care homes or other institutional settings) that had COVID-19 was: 70.7% of the population (38.5 million people) in England 56.0% of the population (1.7 million people) in Wales 72.2% of the population (1.3 million people) in Northern Ireland 51.5% of the population (2.7 million people) in Scotland 27 April 2020 to 11 February 2022 for England 30 June 2020 to 11 February 2022 for Wales 27 July 2020 to 11 February 2022 for Northern Ireland 22 September 2020 to 11 February 2022 for Scotland Coronavirus (COVID-19) Infection Survey technical article: Cumulative incidence of the number of people who have tested positive for COVID-19, UK: 22 April 2022 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsurveytechnicalarticlecumulativeincidenceofthenumberofpeoplewhohavetestedpositiveforcovid19uk/22april2022 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveycharacteristicsofpeopletestingpositiveforcovid19uk/30march2022#re-infections-with-covid-19-uk Number of people who have had at least one episode of coronavirus 27 April 2020 until 11 February 2022 N = 535,116 people in the UK Aged two years and over and were living in private households Each participant was regularly tested during the duration of their time in the study. Swabs were tested using polymerase chain reaction (PCR). We take all positive and negative tests in the survey and apply statistical modelling techniques to estimate the number of people who have had COVID-19 in the population, in each of the four UK nations for the duration of the survey. Daily prevalence and incidence estimated Incidence estimated from prevalence We do this using both positive and negative swab results Positivity (prevalence) from "first infection" episodes a new positive test occurs 120 days or more after an individual's first positive test in the survey, and their most recent prior test result was negative or, last positive test has been followed by four consecutive negative tests Incidence methodology Duration of testing positive varies from person Incidence and duration can be used to give prevalence Reinfections We retest the same people, regardless of whether they have symptoms, we can identify both infections and re-infections, and our data includes asymptomatic cases. Cambridge University modelling 20th February 2020 to 10th February 2022 https://www.mrc-bsu.cam.ac.uk/now-casting/nowcasting-and-forecasting-25th-february-2022/ Estimates 40.2 million people had COVID-19 in England 30% of all infections are re-infections. The risk of re-infection was approximately 10 times higher in the period when the Omicron variants were most common, compared with when the Delta variant was most common Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
In depth talk with Neil Oliver, Tim Kelly and John Campbell. Times have changed. This video contains many serious points for the serious viewer. Check out Neil's channel as well, https://www.youtube.com/@Neil-Oliver Follow Tim on X, https://x.com/DrTimothyKelly Uploaded 21-05-25 Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Useful psychology. The Johari Window and aspects of the self. Uploaded 07-06-25 Open Self Skills Attitudes Knowledge Enlarging will: Increases transparency More authentic relationships Fosters trust Collaboration Stronger connections Blind Self Others can see Self-unaware Non-verbal cues Habits / mannerisms Behavioural tendencies Reducing by: Improves self-awareness Achieved by: Seeking feedback Open to advice Willingness to learn Inhibited by: Pride Denial Hidden (Façade) Self Thoughts Feelings Fears Lusts Values Aspirations Insecurities Reduction by: Self-disclosure Honesty Strengthen relationships Improve emotional connections Inhibited by: Fear of judgment Vulnerability Embarrassments Unknown Self Latent talents Repressed emotions Subconscious beliefs Potential capabilities Reduction by: Self-reflection New experiences Challenges Unexpected circumstances Joseph Luft and Harrington Ingham (1955) Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices
Virus is close to reaching “endemic equilibrium” Update on Balira Uploaded 25-10-21 Link to original Wefeafwa video https://www.youtube.com/watch?v=mV7a9MMFbRg&t=15s If you would like to support our community health outreach in Uganda (100% of donations go directly to Wefwafwa) patreon:https://www.patreon.com/awmedicalvideos Donate: SENDWAVE/ WorldRemit /Western Union/Money Gram Mobile money number:+256785698803 Country: Uganda Registered name : Wefwafwa Andrew State: Eastern uganda Zip code:0000 Wallet Service provider:MTN City: Mbale city please email me when you send or to talk with me directly, wefandrew@gmail.com London School of Hygiene and Tropical Medicine https://www.telegraph.co.uk/news/2021/10/24/coronavirus-cases-slump-winter-say-scientists/ Imminent drops in infections Cases could fall to around 5,000 a day before Christmas Prof John Edmunds, Centre for the Mathematical Modelling of Infectious Diseases, LSHTM Member of SAGE Our model was projecting that cases would start to decline some time in the autumn. However, the model also suggests that cases may start to climb again in the spring, due to a combination of waning immunity and increased contacts Cases currently being driven by high case rates in children Virus is close to reaching “endemic equilibrium” Recent oscillations in case rates will soon level Rishi Sunak at the moment the data does not suggest that we should be immediately moving to 'Plan B Maggie Throup, UK vaccines minister 'Plan A' is working, situation where we need to be United States Pfizer for children, 5 to 11, FDA votes for EMU tomorrow From first half of November 2 shots, 3 weeks gap One third of adult dose 25,000 centres signed up for roll out 28 million children in demographic https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-submit-initial-data-us-fda-pivotal https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-positive-topline-results https://www.businesswire.com/news/home/20210920005452/en/ https://www.fda.gov/media/153447/download Results are the first from a pivotal trial of any COVID-19 vaccine in children under 12 years of age In participants 5 to 11 years of age, the vaccine was safe, well tolerated and showed robust neutralizing antibody responses Phase 2/3 study United States, Finland, Poland, Spain Children 6 months to 11 years of age N = 2,268 5 to 11 years of age Received a 10 µg dose level in a two-dose regimen Strong SARS-CoV-2–neutralizing antibody response, one month after the second dose Continue to accumulate the safety and efficacy data Topline readouts for the other two age cohorts from the trial, soon Children 2-5 years of age Children 6 months to 2 years of age About the Phase 1/2/3 Trial in Children N = 4,500 children ages 6 months to 11 years More than 90 clinical trial sites Children under 5 received a 3 µg dose Trial enrolled children with or without prior evidence of SARS-CoV-2 infection ONS https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights Reduction in self-reported long COVID after vaccination https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19vaccinationandselfreportedlongcovidintheuk/25october2021 Identified themselves as experiencing persistent symptoms 12 weeks after first infection A first vaccine dose was associated with an initial 13% decrease in self-reported long COVID, and a further 9% sustained decrease after receiving the second vaccination No evidence of differences in self-reported between Oxford/AstraZeneca vaccine, compared to Pfizer/BioNTech or Moderna vaccines UK, 30 June to 17 October 2021 Practice falls below thinking https://www.ons.gov.uk/peoplepopul Learn more about your ad choices. Visit megaphone.fm/adchoices
Premiere: Inside mRNA Vaccines https://www.youtube.com/watch?v=BZrJraN2nOQ https://www.youtube.com/watch?v=BZrJraN2nOQ Inside mRNA vaccines https://www.insidemrnavaccines.com/ Filmmaker: Erik Tangsoo Learn more about your ad choices. Visit megaphone.fm/adchoices